CRYO-CELL INTERNATIONAL, INC. Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent
CRYO-CELL INTERNATIONAL, INC. (CCEL) reported Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent of $0 for the 12-month period ending 2019-11-30, per its 10-K filed 2020-02-28.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent · last filed 2020-02-28
- CRYO-CELL INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, net of tax, portion attributable to parent for the quarter ending 2018-11-30 was -$105.14K.
- CRYO-CELL INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, net of tax, portion attributable to parent for the quarter ending 2018-08-31 was $285.25K, a 738.05% increase year-over-year.
- CRYO-CELL INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, net of tax, portion attributable to parent for the quarter ending 2018-05-31 was $1.25K, a 96.28% decline year-over-year.
- CRYO-CELL INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, net of tax, portion attributable to parent for the quarter ending 2018-02-28 was $118.75K.
- CRYO-CELL INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, net of tax, portion attributable to parent for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- CRYO-CELL INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, net of tax, portion attributable to parent for fiscal 2018 was $300.12K, a 4547.96% increase from fiscal 2017.
- CRYO-CELL INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, net of tax, portion attributable to parent for fiscal 2017 was $6.46K.
- CRYO-CELL INTERNATIONAL, INC. other comprehensive income (loss), available-for-sale securities adjustment, net of tax, portion attributable to parent for fiscal 2016 was -$135.52K, a 179.75% decline from fiscal 2015.
| Period end | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2019-11-30 | $0.00 10-K · filed 2020-02-28 | |||
| 2018-11-30 | -$105.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $180.12K derived: sum of 2 quarters · filed 2020-02-28 | $181.37K derived: sum of 3 quarters · filed 2020-02-28 | $300.12K 10-K · filed 2020-02-28 |
| 2018-08-31 | $285.25K 10-Q · filed 2019-10-15 | $286.51K derived: sum of 2 quarters · filed 2019-10-15 | $405.25K 10-Q · filed 2019-10-15 | $351.03K derived: sum of 4 quarters · filed 2019-10-15 |
| 2018-05-31 | $1.25K 10-Q · filed 2018-07-16 | $120.00K 10-Q · filed 2019-07-15 | $65.78K derived: sum of 3 quarters · filed 2019-07-15 | $99.82K derived: sum of 4 quarters · filed 2019-07-15 |
| 2018-02-28 | $118.75K 10-Q · filed 2019-04-15 | $64.53K derived: sum of 2 quarters · filed 2019-04-15 | $98.56K derived: sum of 3 quarters · filed 2019-04-15 | $132.26K derived: sum of 4 quarters · filed 2019-04-15 |
| 2017-11-30 | -$54.22K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$20.18K derived: sum of 2 quarters · filed 2019-02-28 | $13.52K derived: sum of 3 quarters · filed 2019-02-28 | $6.46K 10-K · filed 2019-02-28 |
| 2017-08-31 | $34.04K 10-Q · filed 2018-10-15 | $67.74K derived: sum of 2 quarters · filed 2018-10-15 | $60.68K 10-Q · filed 2018-10-15 | $39.50K derived: sum of 4 quarters · filed 2018-10-15 |
| 2017-05-31 | $33.70K 10-Q · filed 2018-07-16 | $26.64K 10-Q · filed 2018-07-16 | $5.46K derived: sum of 3 quarters · filed 2018-07-16 | -$8.66K derived: sum of 4 quarters · filed 2018-07-16 |
| 2017-02-28 | -$7.06K 10-Q · filed 2018-04-16 | -$28.24K derived: sum of 2 quarters · filed 2018-04-16 | -$42.37K derived: sum of 3 quarters · filed 2018-04-16 | -$48.86K derived: sum of 4 quarters · filed 2018-04-16 |
| 2016-11-30 | -$21.18K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$35.30K derived: sum of 2 quarters · filed 2018-02-28 | -$41.80K derived: sum of 3 quarters · filed 2018-02-28 | -$135.52K 10-K · filed 2018-02-28 |
| 2016-08-31 | -$14.12K 10-Q · filed 2017-10-16 | -$20.61K derived: sum of 2 quarters · filed 2017-10-16 | -$114.34K 10-Q · filed 2017-10-16 | -$87.73K derived: sum of 4 quarters · filed 2017-10-16 |
| 2016-05-31 | -$6.49K 10-Q · filed 2017-07-07 | -$100.22K 10-Q · filed 2017-07-07 | -$73.61K derived: sum of 3 quarters · filed 2017-07-07 | -$156.56K derived: sum of 4 quarters · filed 2017-07-07 |
| 2016-02-29 | -$93.73K 10-Q · filed 2017-04-13 | -$67.11K derived: sum of 2 quarters · filed 2017-04-13 | -$150.07K derived: sum of 3 quarters · filed 2017-04-13 | $76.20K derived: sum of 4 quarters · filed 2017-04-13 |
| 2015-11-30 | $26.61K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$56.34K derived: sum of 2 quarters · filed 2017-02-28 | $169.93K derived: sum of 3 quarters · filed 2017-02-28 | $169.93K 10-K · filed 2017-02-28 |
| 2015-08-31 | -$82.96K 10-Q · filed 2016-10-17 | $143.32K derived: sum of 2 quarters · filed 2016-10-17 | $143.32K 10-Q · filed 2016-10-17 | $143.32K derived: sum of 4 quarters · filed 2016-10-17 |
| 2015-05-31 | $226.28K 10-Q · filed 2016-07-11 | $226.28K 10-Q · filed 2016-07-11 | $226.28K derived: sum of 3 quarters · filed 2016-07-11 | $226.28K derived: sum of 4 quarters · filed 2016-07-11 |
| 2015-02-28 | $0.00 10-Q · filed 2016-04-14 | $0.00 derived: sum of 2 quarters · filed 2016-04-14 | $0.00 derived: sum of 3 quarters · filed 2016-04-14 | |
| 2014-11-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 | |
| 2014-08-31 | $0.00 10-Q · filed 2015-10-15 | $0.00 10-Q · filed 2015-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |